Qkit Procedure Tray
NDC Package 59365-9074-1

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

Qkit Procedure Tray is xylocaine (lidocaine HCl) Injections are indicated for production of local or regional anesthesia by infiltration techniques such as percutaneous injection and intravenous regional anesthesia by peripheral nerve block techniques such as brachial plexus and intercostal and by central neural techniques such as lumbar and caudal epidural blocks, when the accepted procedures for these techniques as described in standard textbooks are observed. Marketed by Coopersurgical, Inc., this product is identified by NDC 59365-9074.

Identification & Billing

NDC Package Code
59365-9074-1
Package Description
5 PACKAGE in 1 PACKAGE / 1 KIT in 1 PACKAGE * 8 mL in 1 VIAL, SINGLE-USE * 8 g in 1 VIAL, SINGLE-USE * 10 mL in 1 VIAL, MULTI-DOSE
Product Code
59365-9074
11-Digit Billing Format
59365907401
RxNorm Crosswalk
  • RxCUI: 1010751 - lidocaine HCl 1 % / EPINEPHrine 1:100,000 Injectable Solution
  • RxCUI: 1010751 - epinephrine 0.01 MG/ML / lidocaine hydrochloride 10 MG/ML Injectable Solution
  • RxCUI: 1010751 - epinephrine (as epinephrine bitartrate) 1:100,000 / lidocaine hydrochloride 1 % Injectable Solution
  • RxCUI: 1010755 - Xylocaine 1 % / EPINEPHrine 1:100,000 Injectable Solution
  • RxCUI: 1010755 - epinephrine 0.01 MG/ML / lidocaine hydrochloride 10 MG/ML Injectable Solution [Xylocaine with Epinephrine]

Clinical Specifications

Proprietary Name
Qkit Procedure Tray
Dosage Form
-
Usage Information
Xylocaine (lidocaine HCl) Injections are indicated for production of local or regional anesthesia by infiltration techniques such as percutaneous injection and intravenous regional anesthesia by peripheral nerve block techniques such as brachial plexus and intercostal and by central neural techniques such as lumbar and caudal epidural blocks, when the accepted procedures for these techniques as described in standard textbooks are observed. Ferric Subsulfate, Aqueous, is a stypic agent used for achieving local hemostasis. In punch biopsies of the full dermis, the time to achieve hemostasis is typically less than 20 seconds.1 One method of applying ferric subsulfate solution for dermal use consists of the physician placing fingers at the opposite edge of the wound and stretching the skin. The wound is then wiped with gauze, the ferric subsulfate solution applied, and the tension maintained for approximately 15 seconds.2 LUGOL’s is a topical antiseptic. Strong Iodine Solution is a germicide and fungicide. LUGOL’s is preservative-free.

Regulatory & Marketing

Labeler Name
Coopersurgical, Inc.
Marketing Category
UNAPPROVED DRUG OTHER - An unapproved drug product in a marketing category that is not reflected on a particular list.
Start Marketing Date
05-31-2015
Listing Expiration
12-31-2022
Exclude Flag
I
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 59365-9074-1 identifies a specific commercial package of 5 package in 1 package / 1 kit in 1 package * 8 ml in 1 vial, single-use * 8 g in 1 vial, single-use * 10 ml in 1 vial, multi-dose of Qkit Procedure Tray, labeled by Coopersurgical, Inc.. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Coopersurgical, Inc. on May 31, 2015. The current certification is valid through December 31, 2022.

How is this Coopersurgical, Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 59365907401. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
59365-9074-1
11-Digit CMS (5-4-2)
59365-9074-01

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.